EIF4A2 Antibody (C-term) Blocking Peptide

Catalog Number: ABT-BP9190B
Article Name: EIF4A2 Antibody (C-term) Blocking Peptide
Biozol Catalog Number: ABT-BP9190B
Supplier Catalog Number: BP9190b
Alternative Catalog Number: ABT-BP9190B-500UG
Manufacturer: Abcepta
Category: Proteine/Peptide
Alternative Names: Eukaryotic initiation factor 4A-II, eIF-4A-II, eIF4A-II, ATP-dependent RNA helicase eIF4A-2, EIF4A2, DDX2B, EIF4F
Eukaryotic initiation factor 4A plays an important role in the binding of mRNA to the 43S preinitiation complex when protein synthesis begins. Two highly homologous forms of functional EIF4A genes, Eif4a1 and Eif4a2, have been isolated in mice, yeast cells also possess 2 EIF4A genes, TIF1 and TIF2. The murine Eif4a and yeast TIF genes appear to belong to a DEAD-box gene family, whose members exhibit extensive amino acid similarity and contain the asp-glu-ala-asp (DEAD) sequence. DEAD-box genes have been identified in species ranging from E-coli to humans. Their function appears to be related to transcriptional/translational regulation (referenced from OMIM).
NCBI: 1974
UniProt: Q14240
Form: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target: The synthetic peptide sequence used to generate the antibody AP9190b was selected from the C-term region of human EIF4A2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.